Deregulation of protein synthesis as a mechanism of neoplastic transformation

BioEssays

Volumn 18, Issue 3, 1996, Pages 243-250

  Rosenwald, Igor B ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL DIVISION; CELL TRANSFORMATION; GENETICS; HUMAN; METABOLISM; ONCOGENE; PHYSIOLOGY; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; ONCOGENE PROTEINS; ONCOGENES; PROTEIN BIOSYNTHESIS;

ANIMALIA;

EID: 0030111237     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950180312     Document Type: Article

References (83)

1. Epifanova, O.I., Setkov, N. A., Polunovsky, V. A. and Terskikh, V. V. (1982). Cellular rest as an active metabolic state. Cell Function and Differentiation, Part A (ed G. Akoyunoglou et al.), pp. 231-242. New York, Alan Liss.
2. Hershko, A., Mamont, P., Shields, B. and Tomkins, G. M. (1971), Pleiotypic response. Nature New Biol. 232, 206-211.
3. Rosenwald, I. B. (1990). Lysosomal inhibitors stimulate NIH 3T3 cells to proliferate. Cell Tiss. Kinet. 23, 463-471.
4. i arrest points. J. Cell. Physiol. 102, 367-378.
5. Lengyel, P. (1993). Tumor-suppressor genes: news about the Interferon connection. Proc. Natl Acad. Sci. USA 90, 5893-5895.
6. Pestka, S., Langer, J. A., Zoon, K. C. and Samuel, C. E. (1987). Interferons and their actions. Ann. Rev. Biochem. 56, 727-777.
7. Heslop, H. E. et al. (1990). Effects of Interferon α on autocrine growth factor loops in B lymphoprolrferative disorders. J. Exp. Med. 172, 1729-1734.
8. Rimoldi, D.. Dieffenbach, C. W., Friedman, R. M. and Samid, D. (1990) 2′-5′ oligoadenylate synthetase gene expression in revenants of ras-transformed NIH 3T3 fibroblasts. Exp. Cell Res. 191, 76-82.
9. Stanners, C. P., Adams, M. E., Harkins, J. L. and Pollard, J. W. (1979) Transformed cells have lost control of ribosome number through their growth cycle. J. Cell. Physiol. 100, 127-138.
10. Blenis, J., Kuo, C. J. and Erikson, R. L. (1987). Identification of a ribosomal protein S6 kinase regulated by transformation and growth-promoting stimuli. J. Biol. Chem. 262, 14373-14376.
11. Spivack, J. G., Erikson, R. L. and Maller, J. L. (1984) Microinjection of pp60v-src into Xenopus oocytes increases phosphorylation of ribosomal protein S6 and accelerates the rate of progesteron-induced meiotic maturation. Mol. Cell. Biol. 4, 1631-1634.
12. Talmage, D. A., Blenis, J. and Benjamin, T. L. (1988). Polyomavirus middle T antigen induces ribosomal protein S6 phosphorylation through pp60c-src dependent and independent pathways. Mol. Cell. Biol. 8, 2309-2315.
13. Barren, C. B., Schroetke, R. M., Van der Hoorn, F. A., Nordeen, S. K., and Maller, J. L. (1990). Ha-ras val-12, thr-59 activates S6 kinase and p34cdc2 kinase in Xenopus oocytes: evidence for c-mosXe-dependent and -independent pathways. Mol. Cell. Biol. 10, 310-315.
14. Kamata, T. and Kung, H.-F. (1990). Modulation of maturation and ribosomal protein S6 phosphorylation in Xenopus oocytes by mtcroinjection of oncogenic ras protein and protein kinase C. Mol. Cell. Biol. 10, 880-886.
15. Maller, J. L., Foulkes, J. G., Erikson, E. and Baltimore, D. (1985). Phosphorylation of ribosomal protein S6 on serine after microinjection of the abelson murine leukemia virus tyrosine-specific protein kinase into Xenopus oocytes. Proc. Natl Acad. Sci. USA 82, 272-276.
16. Lazaris-Karatzas, A., Montine, K. S. and Sonenberg, N. (1990). Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345, 544-546.
17. Lazaris-Karatzas, A. and Sonenberg, N. (1992). The mRNA 5′ cap-binding protein, elF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts. Mol. Cell. Biol. 12, 1234-1238.
18. Sonenberg, N. (1994). Regulation of translation and cell growth by elF-4E. Biochimie76, 839-846.
19. Rhoads, R. E., Joshi, B. and Minich, W. B. (1994). Participation of initiation factors in the recruitment of mRNA to ribosomes. Biochimie 76, 831-838.
20. Smith, M. R. et al. (1990). Translation initiation factors induce DNA synthesis and transform NIH 3T3 cells. The New Biologist 2, 648-654.
21. De Benedetti, A. and Rhoads, R. E. (1990). Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in abberant growth and morphology. Proc. Natl Acad. Sci. USA 87, 8212-8216.
22. Sonenberg, N. (1988). Cap-binding proteins of eukaryotic messenger RNA: functions in initiation and control of translation. Progr. Nucl. Acid Res. Mol. Biol. 35, 173-207.
23. Rinker-Schaeffer, C. W., Austin, V., Zimmer, S. and Rhoads, R. E. (1992). Ras transformation of cloned rat embryo fibroblasts results in increased rates of protein synthesis and phosphorylation of eukaryotic initiation factor 4E. J. Biol. Chem. 267, 10659-10664.
24. De Benedetti, A., Joshi-Barve, S., Rinker-Schaffer, C. and Rhoads, R. E. (1991). Expression of antisense RNA against initiation factor elF-4E mRNA in Hela cells results in lengthened cell division times, diminished translation rates and reduced levels of both elF-4E and p220 component of elF-4F. Mol. Cell. Biol. 11, 5435-5445.
25. Rinkerr-Schaffer, C. W., Graft, J. R., De Benedetti, A., Zimmer, S. G. and Rhoads, R. E. (1993). Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int. J. Cancer 55, 841-847.
26. Frederickson, R. M., Montine, K. S. and Sonenberg, N. (1991). Phosphorylation of eukaryotic translation initiation factor 4E is increased in src-transformed cell lines. Mol. Cell. Biol. 11, 2896-2900.
27. r 68,000 from influenza virus-infected cells. Proc. Natl Acad. Sci.USA 87, 6208-6212.
28. Kitajewski, J. et al. (1986). Adenovirus VAI RNA antagonizes the antiviral action of Interferon by preventing activation of the interferon-induced elF-2a kinase. Cell 45, 195-200.
29. Roy, S., Katze, M. G., Parkin, N. T., Edery, I., Hovanessian, A. G. and Sonenberg, N. (1990). Control of the interferon-induced 68-kilodalton protein kinase by HIV1 tat gene product. Science 247, 1216-1219.
30. r protein kinase to regulate its autophosphorylation and activity. EMBO J. 6, 689-697.
31. Wek, R. C. (1994). elF-2 kinases: regulators of general and gene-specific translation initiation. Trends Biochem. Sci. 19, 491-496.
32. Mundschau, L. J. and Falter, D. V. (1992). Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2u-kinase activation. J. Biol. Chem. 267, 23092-23098.
33. Barber, G. N. et al. (1994). The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. Proc. Natl Acad. Sci. USA 91, 4278-4282
34. Chong, K.L. et al. (1992). Human p68 kinase exhibits growth suppression in yeast and homotogy to the translational regulator GCN2. EMBO J. 11, 1553-1562.
35. Kofomilas, A. E., Roy, S., Barber, G. N., Katze, M. G. and Sonenberg, N. (1992). Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257, 1685-1689.
36. Hanash, S. M. et al. (1993). Mapping of the gene for interferon-inducible dsRNA-dependent protein kinase to chromosome region 2p21-22: a site of rearrangements in myeloproliferative disorders. Genes, Chrom. Cancer 8, 34-37.
37. Rosenwald, I. B. (1995). Growth-factor independent expression of the gene encoding eukaryotic translation initiation factor 4E in transformed cell lines. Cancer Lett. 98, 77-82.
38. Eilers, M., Picard, D., Yamamoto, K. R. and Bishop, J. M. (1989). Chimeras of myc protein and steroid receptors cause hormone-dependent transformation of cells. Nature 340, 66-68.
39. Rosenwald, I. B., Rhoads D. B., Callanan I. D., Isselbacher K. J. and Schmidt, E. V. (1993). Increased expression of translation initiation factors elF-4E and elF-2a in response to growth induction by c-myc. Proc. Natl Acad. Sci. USA 90, 6175-6178.
40. 1 phase progression: cycling on cue. Cell79, 551-555.
41. Hunter, T. and Pines, J. (1994). Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
42. Rosenwald, I. B., Lazaris-Karatzas, A., Sonenberg, N. and Schmidt, E. V. (1993). Elevated expression of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol. Cell. Biol. 13, 7358-7363.
43. Rosenwald I. B. et al. (1995). Eukaryotic translation initiation factor 4E regulates expression of cyclin Dl at transcriptional and post-transcriptional levels. J. Biol. Chem. 270, 21176-21180.
44. Cleveland, J. L., Dean, M., Rosenberg, N., Wang, J. Y. J. and Rapp, U. R. (1989). Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signalling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol. Cell. Biol. 9, 5685-5695.
45. Sawyers, C. L., Callahan, W. and Witte, O. N. (1992). Dominant negative myc blocks transformation by abl oncogenes. Cell 70, 901-910.
46. Rustgi, A. K., Dyson, N. and Bernards, R. (1991 ). Ammo-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352, 541-544.
47. Hiebert, S. W., Chellappan, S. P., Horowitz, J. M. and Nevins, J. R. (1992) The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6, 177-185.
48. Roussel, M. F., Oavis, J. N., Cleveland, J. L., Ghysdael, J. and Hiebert, S. W. (1994). Dual control of c-myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 9, 405-415.
49. Blake, M. C. and Azizkhan, J. C. (1989). Transcription factor E2F is required for the efficient expression of the hamster dehydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9, 4994-5002.
50. Furukawa, Y., Terui, Y., Sakoe, K., Ohta, M. and Saito, M. (1994). The role of cellular transcription factor E2F in the regulation of cdc2 mRNA expression and cell cycle control of human hematopoietic cells. J. Biol. Chem. 269, 26249-26258.
51. 1 cell-cycle arrest. Genes Dev. 9, 204-217.
52. White, E. (1993). Death-defying acts: a meeting review on apoptosis. Genes Dev. 7, 2277-2284.
53. Evan, G. I. et al. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128.
54. Hermeking, H. and Eick, D. (1994). Mediation of c-myc-induced apoptosis by p53. Science 265, 2091-2093.
55. Pause, A. et al. (1994). Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371, 762-767.
56. Lin, T.-A. et al. (1994). PHAS-1 as a link between mitogen-activated protein kinase and translation initiation. Science 266, 653-656.
57. Shantz, L. M. and Pegg, A. E. (1994). Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res. 54, 2313-2316.
58. Lazaris-Karatzas, A. et al. (1992). Ras mediates translation initiation factor 4E-induced malignant transformation. Genes Dev.6, 1631-1642.
59. Rueckert, R. R. and Muetter, G. C. (1960). Studies on unbalanced growth in tissue culture. I. Induction and consequences of thymidine deficiency. Cancer Res. 20, 1584-1592.
60. Segten, P. O. (1987). Regulation of autophagic protein degradation in isolated liver cells. In Lysosomes: Their Role in Protein Breakdown (ed. F. Ballard) pp. 371-414. Academic Press. New York.
61. Jiang, L.-W., Maher, V. M., McCormick, J. J. and Schindler, M. (1990). Alkalinization of the lysosomes is correlated with ras transformation of murine and human fibroblasts. J. Biol. Chem. 265, 4775-4777.
62. Ober, S. S. and Pardee, A. B. (1987). Intracellular pH is increased after transformation of Chinese hamster embryo fibroblasts. Proc. Natl Acad. Sci. USA 84, 2766-2770.
63. Oberhaensli, R. O., Bore, P. J., Rampling, R. P., Hilton-Jones, D., Hands, L. J. and Radda, G. K. (1986). Biochemical investigation of human tumors in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet ii, 8-11.
64. +-ATPase containing site-directed mutations. Mol. Cell. Biol. 10, 4110-4115.
65. Ballard, F. J. (1985). Regulation of protein breakdown by epidermal growth factor in A431 cells. Exp. Cell Res. 157, 172-180.
66. Szego, C. M. and Pietras, R. J. (1984). Lysosomal functions in cellular activation: propagation of the actions of hormones and other effectors. Int. Rev. Cytol. 88, 1-301.
67. Warren, L. (1990). Stimulation of lysosomal enzyme secretion by growth factors. Exp. Cell Res. 190, 133-136.
68. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314.
69. Weber, M. J. et al. (1984). Transport of potassium, amino acids and glucose in cells transformed by Rous sarcoma virus. FASEB J. 43, 107-112.
70. McKeehan, W. L. (1984). Control of normal and transformed cell proliferation by growth factor-nutrient interactions. FASEB J. 43, 113-115.
71. Birnbaum, M. J., Haspel, H. C. and Rosen, O. M. (1987). Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science 235, 1495-1498.
72. Flier, J. S., Mueckler, M. M., Usher, P. and Lodish, H. F. (1987). Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235, 1492-1495.
73. Yamada, H., Omata-Yamada, T. and Lengyel, P. (1991). Characterization of recessive (mediator-) revenants from NIH 3T3 cells transformed with a c-Hras oncogene. J. Biol. Chem. 255, 4002-4009.
74. Kaddurah-Daouk, R., Lillie, J. W., Daouk, G. H., Green, M. R., Kingston, R. and Schimmel, P. (1990). Induction of a cellular enzyme for energy metabolism by transforming domains of adenovirus Ela. Mol. Cell. Biol. 10, 1476-1483.
75. Liebhaber, S. A., Wolf, S. and Schlessinger, D. (1978). Differences in rRNA metabolism of primary and SV40-transformed human fibroblasts. Cell 13, 121-127.
76. White, R. J., Stott, D. and Rigby, W. J. (1990). Regulation of RNA polymerase III transcription in response to Simian virus 40 transformation. EMBO J. 9, 3713-3721.
77. Lockwood, T. D. and Shier, W. T. (1977). Regulation of acid proteases during growth, quiescence and starvation in normal and transformed cells. Nature 267, 252-254.
78. Kundra, V. and Dean, M. F. (1990). Transformed SV3T3 cells have a reduced lysosomal compartment and lower levels of enzyme activity than 3T3 cells. Exp. Cell Res. 189, 93-99.
79. Hoeffer, W. K. and Roeder, R. G. (1985). Enhancement of RNA polymerase III transcription by E1A gene product of adenovirus. Cell 41, 955-963.
80. Yoshinaga, S., Dean, N., Han, M. and Berk, A. J. (1986). Adenovirus stimulation of transcription by RNA polymerase III evidence for an E1A-dependent increase in transcription factor IIIC concentration. EMBO J. 5, 343-354.
81. Leong, K., Brunet, L. and Berk, A. J. (1988). Factors responsible for the higher transcriptional activity of extracts of adenovirus-infected cells fractionate with the TATA box transcription factor. Mol. Cell. Biol. 8, 1765-1774.
82. Lee, W. S., Kao, C. C., Bryant, G. O., Liu, X. and Berk, A. J. (1991). Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell 67, 365-376.
83. Donze, O., Jagus, R., Koromilas, A. E., Hershey, J. W. B. and Sonenberg, N. (1995). Abrogation of translation initiation factor elF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 14, 3828-3834.